• Chronic Lymphocytic Leukemia

I am a hematologist-oncologist dedicated to advancing the care and treatment of patients with chronic lymphocytic leukemia (CLL) and autoimmune cytopenias.

Following my initial medical education at Chicago Medical School, I completed my residency in internal medicine at the University of Michigan. I then undertook fellowship here at The Ohio State University in hematology and oncology, and after completion of my training, I was delighted to join the staff at the OSUCCC – James. In addition to clinical work, I spend time teaching our medical students and resident physicians as an assistant professor in the Department of Hematology.

As a member of the Leukemia Research Program at the OSUCCC – James, I conduct research in the Experimental Hematology Laboratory developing novel therapeutics for autoimmune cytopenias. My research group has an interest in finding optimal strategies for the use of BTK inhibitors, including studying resistance, combination therapies and treatment discontinuation. I am currently the principal investigator on four open and two pending clinical trials in this area, including two investigator-sponsored trials and a NCI study.

I have also written several articles for publication in such medical journals as Leukemia and Cancer Cell, and have prepared numerous abstracts and posters for presentations.

What I love most about The James is working with very passionate and committed team members to give our patients the very best care. I feel that communication is a key aspect to providing the best medical care and enjoy spending time with my patients most of all.